EQUITY - Embodiment, social ineQualities, lifecoUrse epidemiology, cancer and chronIc diseases, intervenTions, methodologY

Equipe constitutive du CERPOP, UMR1295, unité mixte INSERM - Université Toulouse III Paul Sabatier
Florence MOLINIÉ •  chercheure

 

2024

  1. Borghi G, Delacôte C, Delacour-Billon S, Ayrault-Piault S, Dabakuyo-Yonli TS, Delafosse P, Woronoff AS, Trétarre B, Molinié F, Cowppli-Bony A. Socioeconomic Deprivation and Invasive Breast Cancer Incidence by Stage at Diagnosis: A Possible Explanation to the Breast Cancer Social Paradox. Cancers (Basel). 2024 Apr 27;16(9):1701. doi: 10.3390/cancers16091701.
  2. Molinié F, Lafay L, Rogel A. Clarification Regarding Breast Cancer Stage in France. JAMA Oncol. 2024 Apr 25. doi: 10.1001/jamaoncol.2024.0668. Epub ahead of print.
  3. Dantony E, Uhry Z, Fauvernier M, Coureau G, Mounier M, Trétarre B, Molinié F, Roche L, Remontet L. Multidimensional penalized splines for survival models: illustration for net survival trend analyses. Int J Epidemiol. 2024 Feb 14;53(2):dyae033. doi: 10.1093/ije/dyae033.
  4. Delacôte C, Ariza JM, Delacour-Billon S, Ayrault-Piault S, Borghi G, Menanteau K, Bouron A, Métais M, Cowppli-Bony A, Molinié F. Socioeconomic and geographic disparities of breast cancer incidence according to stage at diagnosis in France. Cancer Causes Control. 2024 Feb;35(2):241-251. doi: 10.1007/s10552-023-01779-8.
  5. Sant M, Vener C, Lillini R, Rossi S, Bonfarnuzzo S, Marcos-Gragera R, Maynadié M, Innos K, Paapsi K, Visser O, Bernasconi A, Demuru E, Di Benedetto C, Mousavi SM, Blum M, Went P, Serraino D, Bennett D, Sánchez MJ, De Angelis R; EUROCARE-6 Working Group (Molinié F collaborator). Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study. Lancet Oncol. 2024 Jun;25(6):731-743. doi: 10.1016/S1470-2045(24)00141-4.
  6. Jooste V, Grosclaude P, Defossez G, Daubisse L, Woronoff AS, Bouvier V, Chirpaz E, Tretarre B, Lapotre B, Plouvier S, Launoy G, Bonneault M, Molinié F, Bouvier AM; FRANCIM Network. Net survival in colon and rectal cancer by stage according to neoadjuvant treatment. A French population-based study. Dig Liver Dis. 2024 Jun;56(6):1064-1070. doi: 10.1016/j.dld.2023.10.012.
  7. De Angelis R, Demuru E, Baili P, Troussard X, Katalinic A, Chirlaque Lopez MD, Innos K, Santaquilani M, Blum M, Ventura L, Paapsi K, Galasso R, Guevara M, Randi G, Bettio M, Botta L, Guzzinati S, Dal Maso L, Rossi S; EUROCARE-6 Working Group (Grosclaude P, Molinié F collaborator). Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study. Lancet Oncol. 2024 Mar;25(3):293-307. doi: 10.1016/S1470-2045(23)00646-0.

2023

  1. Delacôte C, Delacour-Billon S, Ayrault-Piault S, Tagri AD, Rousseau G, Vincent M, Amossé S, Delpierre C, Cowppli-Bony A, Molinié F. Is survival rate lower after breast cancer in deprived women according to disease stage? Br J Cancer. 2023 Jan;128(1):63-70. doi: 10.1038/s41416-022-02024-w.
  2. Gardy J, Wilson S, Guizard AV, Bouvier V, Tron L, Launay L, Alves A, On Behalf Of The Francim Group, Launoy G, Molinié F, Bryère J, Dejardin O. Cancer Survival and Travel Time to Nearest Reference Care Center for 10 Cancer Sites: An Analysis of 21 French Cancer Registries. Cancers (Basel). 2023 Feb 28;15(5):1516. doi: 10.3390/cancers15051516.
  3. Poiseuil M, Payet C, Molinié F, Dabakuyo-Yonli TS, Mathoulin-Pelissier S, Amadeo B, Coureau G. Survival after breast cancer according to participation in organised or opportunistic screening and deprivation. Cancer Epidemiol. 2023 Feb;82:102312. doi: 10.1016/j.canep.2022.102312.
  4. Trétarre B, Dantony E, Coureau G, Defossez G, Guizard AV, Delafosse P, Daubisse L, Velten M, Karima Hammas, Barra S, Lapotre B, Plouvier S, d'Almeida T, Molinié F, Woronoff AS. Trends in incidence of invasive vaginal cancer in France from 1990 to 2018 and survival of recently diagnosed women - A population-based study. Eur J Obstet Gynecol Reprod Biol. 2023 Apr;283:125-129. doi: 10.1016/j.ejogrb.2023.02.003.
  5. Tron L, Remontet L, Fauvernier M, Rachet B, Belot A, Launay L, Merville O, Molinié F, Dejardin O, Francim Group, Launoy G. Is the Social Gradient in Net Survival Observed in France the Result of Inequalities in Cancer-Specific Mortality or Inequalities in General Mortality? Cancers (Basel). 2023 Jan 20;15(3):659. doi: 10.3390/cancers15030659.

2022

  1. Bertrand C, Bihan-Benjamin CL, Molinié F, Rogel A, Méric JB, Ifrah N, Bousquet PJ. Care pathway of women with interval breast cancer in 2016, based on medico-administrative data. Clin Breast Cancer. 2022 Jul;22(5):e718-e726. doi: 10.1016/j.clbc.2021.12.003.
  2. Compaoré ZC, Monnet E, Gérazime A, Molinié F, Guizard AV, Delafosse P, Dabakuyo-Yonli TS, Coureau G, Hammas K, Plouvier S, Bara S, Défossez G, Lapôtre-Ledoux B, Daubisse-Marliac L, d'Almeida T, Launoy G, Mansi L, Trétarre B, Woronoff AS. To what extent do age, stage and treatment influence survival after invasive cervical cancer: a French population-based study. Cancer Causes Control. 2022 Mar;33(3):403-415. doi: 10.1007/s10552-021-01536-9. Compaoré ZC, Monnet E, Gérazime A, Molinié F, Guizard AV, Delafosse P, Dabakuyo-Yonli TS, Coureau G, Hammas K, Plouvier S, Bara S, Défossez G, Lapôtre-Ledoux B, Daubisse-Marliac L, d'Almeida T, Launoy G, Mansi L, Trétarre B, Woronoff AS. To what extent do age, stage and treatment influence survival after invasive cervical cancer: a French population-based study. Cancer Causes Control. 2022 Mar;33(3):403-415. doi: 10.1007/s10552-021-01536-9.
  3. Poiseuil M, Tron L, Woronoff AS, Trétarre B, Dabakuyo-Yonli TS, Fauvernier M, Roche L, Dejardin O, Molinié F, Launoy G; French Network of Cancer Registries (FRANCIM). How do age and social environment affect the dynamics of death hazard and survival in patients with breast or gynecological cancer in France? Int J Cancer. 2022 Jan 15;150(2):253-262. doi: 10.1002/ijc.33803.
  4. Ssenyonga N, Stiller C, Nakata K, Shalkow J, Redmond S, Bulliard JL, Girardi F, Fowler C, Marcos-Gragera R, Bonaventure A, Saint-Jacques N, Minicozzi P, De P, Rodríguez-Barranco M, Larønningen S, Di Carlo V, Mägi M, Valkov M, Seppä K, Wyn Huws D, Coleman MP, Allemani C; CONCORD Working Group (Molinié F collaborator). Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000-14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries. Lancet Child Adolesc Health. 2022 Jun;6(6):409-431. doi: 10.1016/S2352-4642(22)00095-5.
  5. Talibov M, Tual S, Morlais F, Meryet-Figuière M, Boulanger M, Bouvier V, Perrier S, Clin B, Baldi I, Lebailly P; AGRICAN group (Molinié F collaborator). Colorectal cancer among farmers in the AGRICAN cohort study. Cancer Epidemiol. 2022 Jun;78:102125. doi: 10.1016/j.canep.2022.102125.

2021

  1. Baicry F, Molinié F, Plouvier S, Colonna M, Daubisse-Marliac L, Grosclaude P, Trétarre B, Bara S, Lapôtre-Ledoux B, Woronoff AS, Guizard AV, Bouvier V, Troussard X, Marrer E, Klein D, Velten M, Jégu J. What is the most appropriate period to define synchronous cancers? Cancer Epidemiol. 2021 Apr;71(Pt A):101900. doi: 10.1016/j.canep.2021.101900.
  2. Bellanger M, Lima SM, Cowppli-Bony A, Molinié F, Terry MB. Effects of fertility on breast cancer incidence trends: comparing France and US. Cancer Causes Control. 2021 Aug;32(8):903-910. doi: 10.1007/s10552-021-01440-2.
  3. Bihan-Benjamin CL, Bertrand C, Molinié F, Rogel A, Méric JB, Ifrah N, Bousquet PJ. Care pathway of women with interval breast cancer in 2016, based on medico-administrative data. Clin Breast Cancer. 2021 Dec 11:S1526-8209(21)00353-0. doi: 10.1016/j.clbc.2021.12.003. Epub ahead of print.
  4. Defossez G, Uhry Z, Delafosse P, Dantony E, d'Almeida T, Plouvier S, Bossard N, Bouvier AM, Molinié F, Woronoff AS, Colonna M, Grosclaude P, Remontet L, Monnereau A; French Network of Cancer Registries (FRANCIM) (Trétarre B, Grosclaude P, Cowppli-Bony A collaborators). Cancer incidence and mortality trends in France over 1990-2018 for solid tumors: the sex gap is narrowing. BMC Cancer. 2021 Jun 24;21(1):726. doi: 10.1186/s12885-021-08261-1.
  5. Girardi F, Rous B, Stiller CA, Gatta G, Fersht N, Storm HH, Rodrigues JR, Herrmann C, Marcos-Gragera R, Peris-Bonet R, Valkov M, Weir HK, Woods RR, You H, Cueva PA, De P, Di Carlo V, Johannesen TB, Lima CA, Lynch CF, Coleman MP, Allemani C; CONCORD Working Group (Trétarre B, Grosclaude P, Cowppli-Bony A, Molinié F  collaborators). The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3). Neuro Oncol. 2021 Oct 1;23(10):1765-1776. doi: 10.1093/neuonc/noab067.
  6. Tron L, Fauvernier M, Bouvier AM, Robaszkiewicz M, Bouvier V, Cariou M, Jooste V, Dejardin O, Remontet L, Alves A, Francim Group, Molinié F, Launoy G. Socioeconomic Environment and Survival in Patients with Digestive Cancers: A French Population-Based Study. Cancers (Basel). 2021 Oct 14;13(20):5156. doi: 10.3390/cancers13205156.
  7. Xiao D, Guizard AV, Daubisse-Marliac L, Woronoff AS, Trétarre B, Delafosse P, Molinié F, Cowppli-Bony A, Lapôtre-Ledoux B, Bara S, Marrer E, Velten M, Laroche L, Heutte N, Grosclaude P, Joly F. Evaluation of long-term living conditions in patients treated for localised prostate cancer. Eur J Cancer Care (Engl). 2021 Jan;30(1):e13333. doi: 10.1111/ecc.13333.
  8. Seigneurin A, Exbrayat C, Molinie F, Croisier L, Poncet F, Berquet K, Delafosse P, Colonna M. THE AUTHORS REPLY. Am J Epidemiol. 2021 Aug 1;190(8):1701-1702. doi: 10.1093/aje/kwab006.

2020

  1. Barul C, Matrat M, Auguste A, Dugas J, Radoï L, Menvielle G, Févotte J, Guizard AV, Stücker I, Luce D; ICARE study group (Trétarre B, Molinié F, Cowppli-Bony A collaborators). Welding and the risk of head and neck cancer: the ICARE study. Occup Environ Med. 2020 May;77(5):293-300. doi: 10.1136/oemed-2019-106080.
  2. Bielska-Lasota M, Rossi S, Krzyżak M, Haelens A, Domenic A, De Angelis R, Maciejczyk A, Rodríguez-Barranco M, Zadnik V, Minicozzi P; EUROCARE-5 Working Group (Trétarre B, Grosclaude P, Cowppli-Bony A, Molinié F collaborators). Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study. Arch Gynecol Obstet. 2020 Feb;301(2):591-602. doi: 10.1007/s00404-019-05412-5.
  3. Bouvier AM, Robaszkiewicz M, Jooste V, Cariou M, Drouillard A, Bouvier V, Nousbaum JB; French Network of Cancer Registries (FRANCIM) (Trétarre B, Grosclaude P, Cowppli-Bony A, Molinié F collaborators). . Trends in incidence of small bowel cancer according to histology: a population-based study. J Gastroenterol. 2020 Feb;55(2):181-188. doi: 10.1007/s00535-019-01636-z.
  4. Sant M, Meneghini E, Bastos J, Rossi PG, Guevara M, Innos K, Katalinic A, Majuelo LG, Marcos-Gragera R, Molinié F, Rapiti E, Vizcaino A, Zadnik V, Minicozzi P; European High Resolution Working Group on breast cancer (Trétarre B collaborator).  Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study. Breast Cancer Res Treat. 2020 Sep;183(2):439-450. doi: 10.1007/s10549-020-05761-9.
  5. Seigneurin A, Exbrayat C, Molinié F, Croisier L, Poncet F, Berquet K, Delafosse P, Colonna M. Association of Mammography Screening With a Reduction in Breast Cancer Mortality: A Modeling Study Using Population-Based Data From 2 French Departments. Am J Epidemiol. 2021 May 4;190(5):827-835. doi: 10.1093/aje/kwaa218.